Importantly, a prominent synergy between BGJ 398 and VEGFR inhibitors (sunitinib and regorafenib) was observed in GIST T-1R cells by calculating the synergy scores via four different computational tools (i.e., ZIP, HSA, Bliss, or Loewe) (Table 2). This evidence concerns the gene KDR and gastrointestinal stromal tumor.